Publications

Pham LL, Sheffield T, Pradeep P, Brown J, Haggard D, Wambaugh J, Judson R, Friedman KP. 2019. Estimating uncertainty in the context of new approach methodologies for potential use in chemical safety evaluation. Curr Opin Toxicol (in press).

Chamberlain AM, Cohen SS, Weston SA, Fox KM, Xiang P Killian JM Qian Y. 2019. Relation of cardiovascular events and deaths to low-density lipoprotein cholesterol level among statin-treated patients with atherosclerotic cardiovascular disease. Am J Cardiol (e-pub ahead of print).

Lee HJ, Kim NH, Jung SY, Go EJ, Song G, Sung MK, Jang JO. Pharmacokinetics of a new ALK5 inhibitor in animal models. Presented at the Korean Society of Pharmaceutical Sciences and Technology Fall Meeting, Korea, October 2004.

Seo EK, Lee HJ, Jung SY, Go EJ, Sung MK, Jang JO, Song G. Discovery of p-glycoprotein modulators from natural products. Presented at the Pharmaceutical Society of Korea Fall Meeting, Korea, October 2004.

Lee HJ, Sung MK, Jang JO, Song G, Go EJ. Pharmacokinetic study of glipizide in healthy male subjects. Presented at the Pharmaceutical Society of Korea Spring Meeting, Korea, March 2005.

Sung MK, Song G, Jang JO, Lee HJ, Gwak HS. Determination of ethambutol in human plasma by a validated HPLC method and its application to single-dose pharmacokinetics. Presented at the Pharmaceutical Society of Korea Spring Meeting, Korea, March 2005.

Song G, Wu H, La-Beck L, Zamboni BA, Strychor S, Santory MM, Deitcher WR, Zamboni WC. Effect of gender on pharmacokinetic disposition of PEGylated liposomal CKD-602(S-CKD602) and optisomal topotecan (TILI) in rats. Cancer Research 70(8):3700 [abstract 3700]. Presented at the American Association of Cancer Research Annual Meeting, Washington DC, April 2010.

Starling BR, Kumar P, Lucas AT, Barroa D, Farnan L, Hendrix L, Giovinazzo H, Song G, Gehrig P, Benson J, Zamboni WC. 2019. Mononuclear phagocyte system function and nanoparticle pharmacology in obese and normal weight ovarian and endometrial cancer patients. Cancer Chemother Pharmacol 83(1):61–70.

Storm HM, Shepard J, Czerkies LM, Kineman B, Cohen SS, Reichert H, Carvalho R. 2019. 2’-Fucosyllactose is well tolerated in a 100% whey, partially hydrolyzed infant formula with Bifidobacterium lactis: A randomized controlled trial. Global Pediat Health 6:1–10. DOI: 10.1177/2333794X19833995.

Klosterbuer A, Neutel JM, Cohen SS, Periman S. Plasma glucose and insulin response to high protein oral nutritional supplements in adults with type 2 diabetes mellitus. Poster at ASPEN 2019 Nutrition Science & Practice Conference, March 2019, Phoenix, AZ.